Publications by authors named "J Vijaya Babu"

The work describes a novel sensing and transportation feasibility of the well-established antifungal drug Flucytosine (5-FC) using a 2D Silicon carbide (SiC) and Germanium-doped Silicon carbide (Ge@SiC) nanosheet via PBE level of Density functional theory. The computational study revealed that the drug molecules adhere to SiC and Ge@SiC sheets, maintaining their structural properties through physisorption on SiC and chemisorption on Ge@SiC. The charge transfer process associated with the adsorption is observed by Lowdin charge analysis and both the SiC and Ge@SiC sheets are identified as a feasible oxidation-based nanosensor for the drug.

View Article and Find Full Text PDF

Background: Lead exposure is a widely acknowledged risk to public health for children and adults. However, despite efforts to phase out major sources over the last several decades, estimates of the prevalence of blood lead exposures and associated risks remain poorly characterized in many low- and middle-income countries.

Objectives:  This study aimed to determine blood lead levels (BLLs) and assess potential sources of lead exposure among urban communities in Chennai, Tamil Nadu.

View Article and Find Full Text PDF

Background: Keratoconus is an etiologically complex, degenerative corneal disease that eventually leads to loss of corneal integrity. Cells in corneal epithelium and endothelium express various types of ion channels that play important roles in ocular pathology. This emphasizes the need of understanding alterations of ion channels in keratoconus.

View Article and Find Full Text PDF
Article Synopsis
  • Immune-related adverse events (irAEs) pose significant risks for patients receiving immune checkpoint inhibitors (ICIs), highlighting the need to identify patients at higher risk and develop strategies to manage these complications.
  • An observational study involving 111 patients found that 40.5% experienced symptomatic irAEs, with higher rates linked to combination ICI therapy and pre-existing autoimmune disorders.
  • Early increases in specific cytokines and T helper cell populations were associated with developing severe irAEs, indicating potential biomarkers for monitoring and targeting therapeutic interventions.
View Article and Find Full Text PDF